BACKGROUND: Telomeres, repetitive DNA capping ends of eukaryotic chromosomes, are important in the maintenance of genomic integrity. Perturbed telomeres are common features of many human malignancies, including colorectal cancer. METHODS: Telomere length (TL), measured by a Monochrome Multiplex Real-Time qPCR, was investigated in tumour tissues, adjacent mucosa, and blood from patients with colorectal cancer with different clinicopathological features and its impact on patient survival. TL was also measured in a limited number of liver metastases, non-cancerous liver tissues or corresponding tissues from the same patients. RESULTS: TL in tumour tissues was shorter than in the adjacent mucosa (P < 0.0001). Shorter TL was observed in tumours with lower stage than in those with advanced stages (P = 0.001). TL was shorter in tumours at the proximal than at the distal sites of the colon (P < 0.0001). Shorter TL was also associated with microsatellite instability (P = 0.001) and mucinous tumour histology (P < 0.0001). Patients with a smaller TL ratio between tumour tissues and the adjacent mucosa were associated with increased overall survival (P = 0.022). Metastasised tumours had shorter telomeres than the adjacent non-cancerous liver tissues (P = 0.0005). CONCLUSIONS: Overall, the results demonstrate differences in TL between tumours and the adjacent mucosa, between tumours located at different sites and association with patient survival.

Department of Histology and Embryology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine The Czech Academy of Sciences Prague Czech Republic

Department of Surgery General University Hospital Prague Prague Czech Republic

Division of Molecular Genetic Epidemiology German Cancer Research Center Heidelberg Germany

Faculty of Medicine and Biomedical Center in Pilsen Charles University Pilsen Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 2006;12:1133–1138. doi: 10.1038/nm1006-1133. PubMed DOI

Heidenreich B, Kumar R. TERT promoter mutations in telomere biology. Mutation Res. 2017;771:15–31. doi: 10.1016/j.mrrev.2016.11.002. PubMed DOI

Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann. N. Y. Acad. Sci. 2004;1019:278–284. doi: 10.1196/annals.1297.047. PubMed DOI

Savage Sharon A. Beginning at the ends: telomeres and human disease. F1000Research. 2018;7:524. doi: 10.12688/f1000research.14068.1. PubMed DOI PMC

Stewenius Y, Gorunova L, Jonson T, Larsson N, Hoglund M, Mandahl N, et al. Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity. Proc.Natl Acad. Sci. USA. 2005;102:5541–5546. doi: 10.1073/pnas.0408454102. PubMed DOI PMC

Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig. Dis. Sci. 2015;60:762–772. doi: 10.1007/s10620-014-3444-4. PubMed DOI PMC

Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal Cancer. Gastroenterology. 2015;149:1177–1190.e3. doi: 10.1053/j.gastro.2015.06.047. PubMed DOI PMC

Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812–816. doi: 10.1126/science.8484121. PubMed DOI

Rampazzo E, Bertorelle R, Serra L, Terrin L, Candiotto C, Pucciarelli S, et al. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br. J. Cancer. 2010;102:1300–1305. doi: 10.1038/sj.bjc.6605644. PubMed DOI PMC

Suraweera N, Mouradov D, Li S, Jorissen RN, Hampson D, Ghosh A, et al. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer. Oncotarget. 2016;7:36474–36488. doi: 10.18632/oncotarget.9015. PubMed DOI PMC

Balc’h EL, Grandin N, Demattei MV, Guyetant S, Tallet A, Pages JC, et al. Measurement of telomere length in colorectal cancers for improved molecular diagnosis. Int. J. Mol. Sci. 2017;18:E1871. doi: 10.3390/ijms18091871. PubMed DOI PMC

Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009;37:e21. doi: 10.1093/nar/gkn1027. PubMed DOI PMC

Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, et al. Telomere length and survival in primary cutaneous melanoma patients. Sci. Rep. 2018;8:10947. doi: 10.1038/s41598-018-29322-9. PubMed DOI PMC

Kroupa M, Polivkova Z, Rachakonda S, Schneiderova M, Vodenkova S, Buchler T, et al. Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients. Genes Chromosomes Cancer. 2018;57:61–69. doi: 10.1002/gcc.22508. PubMed DOI

Rachakonda S, Kong H, Srinivas N, Garcia-Casado Z, Requena C, Fallah M, et al. Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk. Genes Chromosomes Cancer. 2018;57:564–572. doi: 10.1002/gcc.22669. PubMed DOI

Srinivas N, Rachakonda S, Hielscher T, Calderazzo S, Rudnai P, Gurzau E, et al. Telomere length, arsenic exposure and risk of basal cell carcinoma of skin. Carcinogenesis. 2019;15:bgz059. PubMed

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009;55:611–622. doi: 10.1373/clinchem.2008.112797. PubMed DOI

Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J. Clin. Oncol. 2004;22:1807–1814. doi: 10.1200/JCO.2004.09.160. PubMed DOI

Katayama S, Shiota G, Oshimura M, Kawasaki H. Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer. J. Cancer Res. Clin. Oncol. 1999;125:405–410. doi: 10.1007/s004320050294. PubMed DOI

O’Sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, et al. Telomere length in the colon declines with age: a relation to colorectal cancer? Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 2006;15:573–577. PubMed

Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres AJ, Diaz-Rubio E, et al. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma. Cancer. 2006;106:541–551. doi: 10.1002/cncr.21625. PubMed DOI

Valls C, Pinol C, Rene JM, Buenestado J, Vinas J. Telomere length is a prognostic factor for overall survival in colorectal cancer. Colorectal Dis. 2011;13:1265–1272. doi: 10.1111/j.1463-1318.2010.02433.x. PubMed DOI

Benitez-Buelga C, Sanchez-Barroso L, Gallardo M, Apellániz-Ruiz M, Inglada-Pérez L, Yanowski K, et al. Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients. Breast Cancer Res.Treat. 2015;149:385–394. doi: 10.1007/s10549-014-3246-6. PubMed DOI PMC

Boardman LA, Johnson RA, Viker KB, Hafner KA, Jenkins RB, Riegert-Johnson DL, et al. correlation of chromosomal instability, telomere length and telomere maintenance in microsatellite stable rectal cancer: a molecular subclass of rectal cancer. Plos One. 2013;8:e80015. doi: 10.1371/journal.pone.0080015. PubMed DOI PMC

Walther A, Houlston R, Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut. 2008;57:941–950. doi: 10.1136/gut.2007.135004. PubMed DOI

Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, et al. Colorectal cancer: a tale of two sides or a continuum? Gut. 2012;61:794–797. doi: 10.1136/gutjnl-2012-302014. PubMed DOI PMC

Missiaglia E, Jacobs B, D’Ario G, Di Narzo AF, Soneson C, Budinska E, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann.Oncol. 2014;25:1995–2001. doi: 10.1093/annonc/mdu275. PubMed DOI

Paschke S, Jafarov S, Staib L, Kreuser ED, Maulbecker-Armstrong C, Roitman M, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int. J. Mol.Sci. 2018;19:E2577. doi: 10.3390/ijms19092577. PubMed DOI PMC

Takagi S, Kinouchi Y, Hiwatashi N, Nagashima F, Chida M, Takahashi S, et al. Relationship between microsatellite instability and telomere shortening in colorectal cancer. Dis. Colon Rectum. 2000;43(10 Suppl):S12–S17. doi: 10.1007/BF02237220. PubMed DOI

Chatterjee N, Walker GC. Mechanisms of DNA damage, repair, and mutagenesis. Environ. Mol. Mutagenesis. 2017;58:235–263. doi: 10.1002/em.22087. PubMed DOI PMC

Loayza D, De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 2003;423:1013–1018. doi: 10.1038/nature01688. PubMed DOI

Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma

Editorial: Current understanding of genomic and chromosomal instabilities in solid malignancies

The dynamics of telomere length in primary and metastatic colorectal cancer lesions

Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients' outcomes

Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium

Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers